By MEG HOSSLER
After many years of research and testing, the University of Georgia Cancer Center has developed a cancer vaccine. They announced their findings in early December and are currently working to find medical patients to participate in trials.
The cancer vaccine is aimed primarily toward breast and pancreatic cancer, and researchers plan to begin human testing by the year 2013. University of Georgia professor Geert-Jan Boons announced that the vaccine is to be ready for human use in as little as three years after assuring test results.
“The reports of this year from the American Cancer Society contain some welcoming information, namely that cancer death rates have declined in men and women over the past ten years,” said Deputy Chief Medical Officer for American Cancer Society Leonard Lichtenfeld. “These findings have proven there have been many enhancements in the cancer field, but this vaccine is one of the greatest findings yet.”
Results from labs showed that the vaccine worked successfully on breast and pancreatic cancer, two of the deadliest forms of cancer. University of Georgia researchers reported that the vaccine worked on 90 percent of breast cancer cases in rats. The American Cancer Society estimated more than one million cancer deaths have been avoided since the year 1992, and this vaccine will ensure the continuation of this survival rate.
“The discovery of a cancer vaccine would change my life and the lives of those I love extensively,” said cancer victim Joy Layton. “I would be able to live a positive life without my depression. I believe the world would be a happier place.”
This discovery has allowed doctors to examine other factors in the fight against cancer that have not been acknowledged, such as the idea of mass producing a vaccine rather than making specific vaccines for each person. This vaccine will benefit the pharmaceutical field by offering more effective medication to cancer patients.
“A vaccine activates the body’s immune system to be able to recognize and destroy cancer cells,” said biology teacher Barbara Clark. “I know that other successful cancer vaccines have benefitted our species. The idea that one can eliminate the fear or suffering of cancer by receiving a vaccine is invaluable.”
This new vaccine trains the immune system to identify cancer cells based on their sugar structures and then destroys the cell. It first breaks down the outer layering of the cancer cell. Then it reduces the size of the cancerous cell until it is completely destroyed.
“I am hopeful that a successful cancer treatment will someday be developed,” said Fox News Medical Contributor Dr. Manny Alvarez. “My hopes are high that this will be an applicable treatment for all those cancer patients out there who currently face painfully limited choices.”
Researchers have stated that there are important factors that must be observed. These incluede potential side effects of the vaccine and long-term survival rates.
“I would imagine a cancer vaccine would not come right away, but after time and study, I think someday we will find the answer,” said freshman Melinda Efta. “We have so many brilliant people in this world that a cure will be found.”
After many years of research and testing, the University of Georgia Cancer Center has developed a cancer vaccine. They announced their findings in early December and are currently working to find medical patients to participate in trials.
The cancer vaccine is aimed primarily toward breast and pancreatic cancer, and researchers plan to begin human testing by the year 2013. University of Georgia professor Geert-Jan Boons announced that the vaccine is to be ready for human use in as little as three years after assuring test results.
“The reports of this year from the American Cancer Society contain some welcoming information, namely that cancer death rates have declined in men and women over the past ten years,” said Deputy Chief Medical Officer for American Cancer Society Leonard Lichtenfeld. “These findings have proven there have been many enhancements in the cancer field, but this vaccine is one of the greatest findings yet.”
Results from labs showed that the vaccine worked successfully on breast and pancreatic cancer, two of the deadliest forms of cancer. University of Georgia researchers reported that the vaccine worked on 90 percent of breast cancer cases in rats. The American Cancer Society estimated more than one million cancer deaths have been avoided since the year 1992, and this vaccine will ensure the continuation of this survival rate.
“The discovery of a cancer vaccine would change my life and the lives of those I love extensively,” said cancer victim Joy Layton. “I would be able to live a positive life without my depression. I believe the world would be a happier place.”
This discovery has allowed doctors to examine other factors in the fight against cancer that have not been acknowledged, such as the idea of mass producing a vaccine rather than making specific vaccines for each person. This vaccine will benefit the pharmaceutical field by offering more effective medication to cancer patients.
“A vaccine activates the body’s immune system to be able to recognize and destroy cancer cells,” said biology teacher Barbara Clark. “I know that other successful cancer vaccines have benefitted our species. The idea that one can eliminate the fear or suffering of cancer by receiving a vaccine is invaluable.”
This new vaccine trains the immune system to identify cancer cells based on their sugar structures and then destroys the cell. It first breaks down the outer layering of the cancer cell. Then it reduces the size of the cancerous cell until it is completely destroyed.
“I am hopeful that a successful cancer treatment will someday be developed,” said Fox News Medical Contributor Dr. Manny Alvarez. “My hopes are high that this will be an applicable treatment for all those cancer patients out there who currently face painfully limited choices.”
Researchers have stated that there are important factors that must be observed. These incluede potential side effects of the vaccine and long-term survival rates.
“I would imagine a cancer vaccine would not come right away, but after time and study, I think someday we will find the answer,” said freshman Melinda Efta. “We have so many brilliant people in this world that a cure will be found.”
RSS Feed